Follow The Filings

Latigo Biotrapeutics Inc.

Filed as LATIGO BIOTRAPEUTICS INC (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed

  • 1 Owner
  • Max 0.1%
  • $14M
  • 1 new

In 2026 Q3 Farallon Capital Management opened a position in Latigo Biotrapeutics.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Farallon Capital Management). Not free-float ownership.

  1. Farallon Capital Management New 0.06%

Holders

Sorted by value, long equity only, as of 2026 Q3.

History
Farallon Capital Management 0.06% New 0.06% 850,000 $14M History

Weight bar: held both quarters added sold at this quarter’s reported price

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Period archive

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf